San Francisco, CA, USA) will erase Genentech's 2008 $3.4 billion net income from the biotech landscape. That stream of revenue will not be easily replaced. Retreat by the public markets If a good ...

San Francisco, CA, USA) together accounted for almost one–third of the sector revenue and one–quarter of the R&D spend. For biotech company financing, 2006 was the biggest year ever ...